NCT00796302
Treatment of Severe Childhood Aggression (The TOSCA Study)
See it on ClinicalTrials.gov β168 people
23.2%
76.8%
39 womenmiddle line = equal numbers129 men
- Phase
- PHASE4
- Paid for by
- Michael Aman
- Finished
- 2012-11
- Health conditions
- Attention Deficit Disorder With Hyperactivity
- Who could join
- Anyone
- Ages
- 6 Years β 12 Years
- Average age
- mean 8.9 years
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
βMaximum age: 12 Years.β
- No pregnant women
Women who were pregnant could not join.
βPregnancy or a history of seizure disorder or other neurological or medical disorders for which medication may present a considerable riskβ
- No diabetes
Women with diabetes were turned away.
βFamily history of type II diabetes in two or more first degree relatives, defined as biological parents and/or full biological siblingsβ
- No seizures
Women with epilepsy or past seizures were turned away.
βPregnancy or a history of seizure disorder or other neurological or medical disorders for which medication may present a considerable riskβ
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
βPervasive developmental disorder, schizophrenia or other psychotic disorders, or eating disordersβ
Study titles and rules are shown in their original English.